Apogee Therapeutics, Inc. Common Stock (APGE) — Financial Flexibility Index
Apogee Therapeutics, Inc. Common Stock (APGE) has a Financial Flexibility Index of -1.47x as of March 2026. Free cash flow of $-55.57 Million (operating CF $-55.57 Million minus capex $0.00) represents -1% of total liabilities ($37.86 Million). Check Apogee Therapeutics, Inc. Common Stock (APGE) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Apogee Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Apogee Therapeutics, Inc. Common Stock across 4 annual periods. See Apogee Therapeutics, Inc. Common Stock (APGE) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Apogee Therapeutics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Apogee Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see Apogee Therapeutics, Inc. Common Stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.69x | $-222.30 Million | $-227.45 Million | $33.25 Million | ▼ -46.1% |
| 2024 | -4.58x | $-170.02 Million | $-171.17 Million | $37.16 Million | ▼ -31.8% |
| 2023 | -3.47x | $-74.59 Million | $-74.76 Million | $21.49 Million | ▼ -110.9% |
| 2022 | -1.65x | $-16.43 Million | $-16.43 Million | $9.98 Million | — |